...
首页> 外文期刊>International Journal of Nursing Sciences >An mHealth intervention to improve medication adherence among patients with coronary heart disease in China: Development of an intervention
【24h】

An mHealth intervention to improve medication adherence among patients with coronary heart disease in China: Development of an intervention

机译:在中国改善冠心病患者药物依从性的mHealth干预措施:干预措施的发展

获取原文
           

摘要

ObjectivesWith this study, we aimed to develop a mobile technology (mHealth) intervention to improve medication adherence among patients with coronary heart disease (CHD).MethodsThe study was conducted in two phases with CHD patients from a Cardiology Department of a hospital located in China. Each phase was independent from the other. Phase 1 tested the integration of the two apps — “WeChat” and “BB Reminder” — as an mHealth intervention. All participants received the same educational materials via WeChat every two days. Participants in the experimental group received a reminder from BB Reminder for every dose of their medications. The duration of Phase 1 was 30 days for each participant. Phase 2 refined the intervention, in which educational materials were sent every five days rather than every two days, and medication-taking reminders were sent daily rather than every dose.ResultsIn Phase 1, an mHealth intervention was developed by integrating two mobile apps. In Phase 2, medication adherence increased at 30-day follow-up in both groups compared to baseline. At the 30-day follow-up, the mean of the decrease in medication non-adherence score in the experimental group (M?=??1.35,SD?=?2.18,n?=?36) was more than the decrease in control group (M?=??0.69, SD?=?1.58,n?=?36), which means the medication adherence improved more in the experimental group.ConclusionThe feasibility of using mHealth to remind CHD patients to take their medications is high.
机译:目的本研究旨在开发一种可改善冠心病(CHD)患者对药物依从性的移动技术(mHealth)干预方法。该研究分两个阶段对来自中国一家医院心血管科的CHD患者进行了研究。每个阶段都相互独立。第一阶段测试了这两种应用程序(“微信”和“ BB提醒”)的集成,以作为mHealth干预措施。所有参与者每两天通过微信收到相同的教育材料。实验组的参与者从BB Reminder那里收到每剂药物的提醒。每个参与者的第一阶段持续时间为30天。第2阶段改进了干预措施,在该干预措施中,每五天而不是每两天发送一次教学材料,并且每天而不是每剂都发送服药提醒。结果在第1阶段,通过集成两个移动应用程序开发了mHealth干预措施。在第2阶段,与基线相比,两组在30天随访时药物依从性均增加。在30天的随访中,实验组药物非依从性得分降低的平均值(M≥1.35,SD≥2.18,n≥36)大于降低幅度。对照组(M≥0.69,SD≥1.58,n≥36),这意味着实验组的药物依从性改善了更多。结论使用mHealth提醒冠心病患者服药的可行性很高。 。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号